Literature DB >> 7089785

The effect of tri-potassium di-citrato bismuthate on the duodenal mucosa during ulceration. An ultrastructural study.

M A Gregory, M G Moshal, J M Spitaels.   

Abstract

The manner in which tri-potassium di-citrato bismuthate (TDB) promotes duodenal ulcer healing is not known. Endoscopic biopsy specimens were taken from the edges of duodenal ulcers from 5 patients before and after treatment with TDB. Using the bismuth contained within this drug as an electron-dense marker, the mode of action of TDB was determined by transmission electron microscopy. TDB was found to promote ulcer healing by adhering to the ulcerative mucosa, thereby providing an effective barrier to the substances which cause and maintain ulceration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7089785

Source DB:  PubMed          Journal:  S Afr Med J


  2 in total

1.  Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study.

Authors:  F I Tovey; E M Husband; Y C Yiu; L Baker; G McPhail; M R Lewin; A P Jayaraj; C G Clark
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

Review 2.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.